Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
3
×
life sciences
national blog main
new york blog main
3
×
antibiotics
boston blog main
boston top stories
deals
drugs
national top stories
new york
new york top stories
san diego
san diego blog main
san diego top stories
the medicines company
achaogen
adams street partners
alirocumab
alnylam pharmaceuticals
amgen
arvinas
astrazeneca
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
boston
boulder/denver
boulder/denver blog main
boulder/denver top stories
carbapenem-resistant enterobacteriaceae
celgene
detroit
detroit blog main
detroit top stories
drug resistance
entasis therapeutics
evolocumab
gritstone oncology
What
company
3
×
drug
medicines
acquire
agreed
bacteria
billion
biopharma
biotechs
brings
business
cash
cholesterol
chose
close
compound
deal
device
disease
exited
fda
fighting
firms
infections
infectious
ipo
ipos
launches
life
make
medco
medical
melinta
new
novartis
open
poised
products
q
qpex
Language
unset
Current search:
fda
×
company
×
" new york blog main "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way